Prellis Biologics pioneers tissue engineering for drug development and organ transplantation. By bioprinting vascularized human tissue and organs with unprecedented speed and resolution, they transform healthcare. Founded in 2016 in San Francisco, California, their innovative technology breaks the microvasculature barrier, promising a healthcare revolution.
